News & Articles

New study finds that persistent COVID-19 infections are surprisingly common, with around one to three in every 100 infections lasting a month or longer

A recent study has revealed the effectiveness of COVID-19 vaccines in preventing long COVID

Researchers explore the challenges of scaling and combining quantum devices (qubits) for applications like climate modeling

Test could allow clinicians to screen for individuals at high risk of developing the disease and facilitate the introduction of precision therapies that are at clinical trial stage

Innovative machine learning approach used to develop a tiny model capable of running on a satellite’s limited processing power

The new research describes a minimally invasive and inexpensive blood test that could identify cancer in patients with non-specific symptoms

Study will assess the immune response of the vaccine which is based on a genetically modified version of a common cold virus

A study by researchers at Oxford University found that we are amidst the biggest decrease in life expectancy since WWII

The genomic sequencing platform facilitates the discovery and action of new, potentially harmful coronavirus mutations worldwide

A large proportion of patients with impaired immune systems mount a low, or undetectable, immune response after two doses of COVID-19 vaccine

Researchers announce the results of a study into thrombocytopenia and thromboembolic events following Covid-19 vaccination

Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant

Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic

Findings explain higher risk of heart attack in people with diabetes, even after treatment

Largest review of all large-scale studies to date finds red and processed meat increase the risk of heart disease

Mixed schedules involving Pfizer-BioNTech and Oxford-AstraZeneca generate strong immune response against SARS-CoV2 spike IgG protein

The risk of CHD can be greatly reduced if the mother is given iron supplements very early in pregnancy

Collaboration follows successful acquisition and commercialization of Oxsed, an Oxford University Spin-out, to scale OxLAMP rapid COVID-19 test globally